These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38129491)

  • 1. Investigation of SARS-CoV-2 individual proteins reveals the in vitro and in vivo immunogenicity of membrane protein.
    Haystead T; Lee E; Cho K; Gullickson G; Hughes P; Krafsur G; Freeze R; Scarneo S
    Sci Rep; 2023 Dec; 13(1):22873. PubMed ID: 38129491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication
    Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Zapata-Builes W; Taborda N; Rugeles MT; Hernandez JC
    Front Immunol; 2023; 14():1161135. PubMed ID: 37180105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death.
    Jeong GU; Lyu J; Kim KD; Chung YC; Yoon GY; Lee S; Hwang I; Shin WH; Ko J; Lee JY; Kwon YC
    Microbiol Spectr; 2022 Jun; 10(3):e0109122. PubMed ID: 35510852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA; Aderogba MA; Sharp HL; Nash RJ
    Phytother Res; 2021 Dec; 35(12):6963-6973. PubMed ID: 34697842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens.
    Morhart P; Kehl S; Schuh W; Hermes K; Meltendorf S; Neubert A; Schneider M; Brunner-Weinzierl M; Schneider H; Lingel H
    In Vivo; 2023; 37(1):70-78. PubMed ID: 36593041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
    Granato G; Gesmundo I; Pedrolli F; Kasarla R; Begani L; Banfi D; Bruno S; Lopatina T; Brizzi MF; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Front Immunol; 2023; 14():1231363. PubMed ID: 37649486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.
    Ruiz MJ; Siracusano G; Cottignies-Calamarte A; Tudor D; Real F; Zhu A; Pastori C; Capron C; Rosenberg AR; Temperton N; Cantoni D; Liao H; Ternette N; Moine P; Godement M; Geri G; Chiche JD; Annane D; Cramer Bordé E; Lopalco L; Bomsel M
    Front Immunol; 2022; 13():842468. PubMed ID: 36248831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
    Chung NH; Chen YC; Yang SJ; Lin YC; Dou HY; Hui-Ching Wang L; Liao CL; Chow YH
    Vaccine; 2022 Jan; 40(4):574-586. PubMed ID: 34952759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
    J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
    Boley PA; Lee CM; Schrock J; Yadav KK; Patil V; Suresh R; Lu S; Feng MM; Hanson J; Channappanavar R; Kenney SP; Renukaradhya GJ
    J Nanobiotechnology; 2023 Feb; 21(1):60. PubMed ID: 36814238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice.
    Hwang IC; Valeriano VD; Song JH; Pereira M; Oh JK; Han K; Engstrand L; Kang DK
    Microb Cell Fact; 2023 May; 22(1):96. PubMed ID: 37161468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.
    Schroeder JT; Bieneman AP
    Front Immunol; 2022; 13():831763. PubMed ID: 35392091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
    Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
    Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model.
    Farshidi N; Ghaedi T; Hassaniazad M; Eftekhar E; Gouklani H; Farshidi H; Asadi Karam MR; Shahbazi B; Kalani M; Ahmadi K
    Microb Pathog; 2022 Oct; 171():105736. PubMed ID: 36030048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.